← Browse by Condition
Medical Condition

pmbl

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06830031 Phase 1
Recruiting

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

Enrollment
18 pts
Location
China
Sponsor
Shanghai Exuma Biotechnology L...
View Trial →